Range
4.44 - 4.99
Vol / Avg.
643.3K/489.4K
Div / Yield
-
52 Wk
4.01 - 13.81
Mkt Cap
74.5M
Payout Ratio
-
Open
4.95
P/E
-
EPS
-3.57
Shares
15.6M
Outstanding
15.6M
Total Float
14.1M
Benzinga - 5 days ago
Benzinga - Jun 11, 2021, 7:33AM
Benzinga - Jun 4, 2021, 9:07AM
Benzinga - May 18, 2021, 7:35AM
Benzinga - May 12, 2021, 7:32AM
Benzinga - May 7, 2021, 8:06AM
Benzinga - May 4, 2021, 7:42AM
Benzinga - Apr 22, 2021, 8:10AM
Benzinga - Apr 8, 2021, 10:43AM
Benzinga - Apr 8, 2021, 8:34AM
Benzinga - Apr 5, 2021, 7:17AM
Benzinga - Apr 5, 2021, 7:16AM
Benzinga - Mar 29, 2021, 7:40AM
Benzinga - Mar 29, 2021, 7:32AM
Benzinga - Mar 26, 2021, 4:13PM
Benzinga - Mar 15, 2021, 12:55PM
Benzinga - Mar 15, 2021, 11:55AM
Benzinga - Mar 15, 2021, 8:02AM
Benzinga - Mar 15, 2021, 6:38AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-20
REV
Q1 2021Est.ActualSurprise
EPS-0.710-0.470 0.2400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
OCUPOcuphire Pharma-1.05%74.5M

Ocuphire Pharma Frequently Asked Questions

Q

How do I buy Ocuphire Pharma (OCUP) stock?

A

You can purchase shares of Ocuphire Pharma (NASDAQ: OCUP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ocuphire Pharma's (OCUP) competitors?

A

Other companies in Ocuphire Pharma’s space includes: Graybug Vision (NASDAQ:GRAY), Opiant Pharmaceuticals (NASDAQ:OPNT), Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).

Q

What is the target price for Ocuphire Pharma (OCUP) stock?

A

The latest price target for Ocuphire Pharma (NASDAQ: OCUP) was reported by Alliance Global Partners on April 5, 2021. The analyst firm set a price target for 25.00 expecting OCUP to rise to within 12 months (a possible 425.21% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ocuphire Pharma (OCUP)?

A

The stock price for Ocuphire Pharma (NASDAQ: OCUP) is $4.76 last updated Today at 8:00:04 PM.

Q

Does Ocuphire Pharma (OCUP) pay a dividend?

A

There are no upcoming dividends for Ocuphire Pharma.

Q

When is Ocuphire Pharma (NASDAQ:OCUP) reporting earnings?

A
Ocuphire Pharma’s Q2 earnings are confirmed for after-market on August 20, 2021.
Q

Is Ocuphire Pharma (OCUP) going to split?

A

There is no upcoming split for Ocuphire Pharma.

Q

What sector and industry does Ocuphire Pharma (OCUP) operate in?

A

Ocuphire Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.